Profound Net Borrowings from 2010 to 2025

PROF Stock  USD 6.93  0.22  3.08%   
Profound Medical's Net Borrowings is increasing over the last several years with stable swings. Net Borrowings is estimated to finish at about 6.5 M this year. Net Borrowings is the difference between the amount of new debt Profound Medical Corp has taken on and the amount of debt it has paid off during a given period. View All Fundamentals
 
Net Borrowings  
First Reported
2018-09-30
Previous Quarter
-279 K
Current Value
-239 K
Quarterly Volatility
3.9 M
 
Covid
Check Profound Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Profound Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 M, Interest Expense of 731 K or Selling General Administrative of 6.9 M, as well as many indicators such as Price To Sales Ratio of 25.53, Dividend Yield of 0.0 or PTB Ratio of 3.51. Profound financial statements analysis is a perfect complement when working with Profound Medical Valuation or Volatility modules.
  
Check out the analysis of Profound Medical Correlation against competitors.

Latest Profound Medical's Net Borrowings Growth Pattern

Below is the plot of the Net Borrowings of Profound Medical Corp over the last few years. It is the difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period. Profound Medical's Net Borrowings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Profound Medical's overall financial position and show how it may be relating to other accounts over time.
Net Borrowings10 Years Trend
Pretty Stable
   Net Borrowings   
       Timeline  

Profound Net Borrowings Regression Statistics

Arithmetic Mean2,458,142
Coefficient Of Variation202.45
Mean Deviation3,337,057
Median2,467,855
Standard Deviation4,976,499
Sample Variance24.8T
Range21.9M
R-Value0.18
Mean Square Error25.6T
R-Squared0.03
Significance0.49
Slope192,403
Total Sum of Squares371.5T

Profound Net Borrowings History

20256.5 M
20246.2 M
20226.9 M
2021-386 K
2020-9.6 M
2019-1.2 M
201812.3 M

About Profound Medical Financial Statements

Profound Medical stakeholders use historical fundamental indicators, such as Profound Medical's Net Borrowings, to determine how well the company is positioned to perform in the future. Although Profound Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Profound Medical's assets and liabilities are reflected in the revenues and expenses on Profound Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Profound Medical Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Borrowings6.2 M6.5 M

Currently Active Assets on Macroaxis

When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:
Check out the analysis of Profound Medical Correlation against competitors.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.34)
Revenue Per Share
0.38
Quarterly Revenue Growth
0.639
Return On Assets
(0.45)
Return On Equity
(0.90)
The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.